In a recent study, talk therapy in Parkinson’s disease led to significant improvement in patients' well-being, ...

The study may suggest that other researchers should be less optimistic about the prospects for treating a range of other ...

Americans will soon have access to an infusion device that provides round-the-clock effective relief of Parkinson's disease.

A compound that showed early promise in the treatment of Parkinson's disease in fruit flies has also shown neuroprotective ...

A new study reveals disappointing results on the potential of GLP-1 drugs like Ozempic to treat Parkinson's disease. Despite ...

The FDA has approved the first and only subcutaneous apomorphine infusion device, apomorphine hydrochloride injection (Onapgo ...

AI-powered blood test detects Parkinson's disease years before symptoms appear, revolutionizing early diagnosis and treatment strategies.

From a study that analyzed brain images of more than 2,500 people with Parkinson's disease in 20 different countries, scientists were able to identify patterns of neurodegeneration and create metrics ...

The US Food and Drug Administration has approved Onapgo (apomorphine hydrochloride) injection as the first and only subcutaneous apomorphine infusion device for the treatment of motor fluctuations in ...

The U.S. Food and Drug Administration has approved Supernus Pharmaceuticals' drug-device combination to treat ...

The 194 people with Parkinson’s disease involved ... maintained stable movement symptoms, while the placebo group worsened. Even after a two-month break from treatment, the lixisenatide group ...